Boston Scientific Corp (BSX) Stock Price, Quote & News

Company Profile

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates in two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat a range of gastrointestinal conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes, as well as endoluminal sur...

Industry: Medical Devices

Sector: Healthcare

Phone: 508 683 4000

Website: www.bostonscientific.com

Address:

300 Boston Scientific Way, Marlborough, United States

ZacksResearch Aug. 22 at 1:08 PM

AI is revolutionizing healthcare — is it time to invest in $BSX, $JNJ, $GEHC, or $TEM? 🚀 🩺 BSX boasts strong growth with AI in heart diagnostics and mapping systems. 🤖 JNJ leverages AI in surgical robotics and digital ecosystems. 🖥️ GEHC focuses on AI-powered imaging and diagnostics. 🔬 TEM excels in AI-driven precision medicine for personalized care. Discover which stock might lead the charge in AI-enabled medical innovation 👉 https://www.zacks.com/stock/news/2741358/4-medical-devices-behemoths-to-buy-amid-extensive-ai-applications?cid=sm-stocktwits-2-2741358-body-9015&ADID=SYND_STOCKTWITS_TWEET_2_2741358_BODY_9015

0 · Reply

BidToBlack Aug. 22 at 3:23 AM

$BSX Medical device company with strong product pipeline and exposure to structural heart and rhythm management

0 · Reply

SilverEagle Aug. 21 at 3:27 PM

$ABT $ABBV $MDT $BSX $XLV

0 · Reply

iSayStupidStuff Aug. 21 at 11:49 AM

$BSX that’s great but I only want it if it’s going up and I’m not seeing volume coming in.

0 · Reply

JFDI Aug. 20 at 10:58 PM

$BSX not BSC

0 · Reply

WAJeff Aug. 20 at 8:40 PM

Added more $BSX 106.20, $HALO 71.05

2 · Reply

SilverEagle Aug. 20 at 8:17 PM

$BSX 120-125 to complete the measured move. Then sideways.

2 · Reply

TechTraderGrok Aug. 20 at 8:05 PM

Bought $BSX at $105.9. From Grok: "Entering long on confirmed uptrend with price above both EMA and SMA after recent breakout from consolidation, supported by positive momentum and no immediate catalysts, targeting multi-week hold towards resistance near 107-108." https://www.techtrader.ai/grokwall/?post=14546&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

BioTechHealthX Aug. 20 at 6:18 PM

$BSX Boston Scientific is being hailed as a forever stock with unstoppable growth in AI, cardiology, and global markets. Learn more here! https://biotechhealthx.com/biotech-news/analysts-call-boston-scientific-bsx-a-forever-company-for-investors/

0 · Reply

JFDI Aug. 20 at 5:00 PM

$BSX fav set up rn

0 · Reply

Boston Scientific Corporation Is Expensive But Worth It

Aug 7, 2025, 9:45 PM EDT - 14 days ago

Baron Capital's Top Health Care Stock Picks And Misses From Q2 2025

ACLX EW EXAS GH ISRG LLY MASI

Aug 6, 2025, 8:07 AM EDT - 16 days ago

Former FDA Director and Boston Scientific Leaders Join Keyron Ahead of Human Trials of First Device with Metabolic Surgery-Like Results Without Incisions

Jul 31, 2025, 9:52 AM EDT - 21 days ago

10 stocks favored to gain up to 30% in a sector that has missed this year's rally

CAH DXCM EW ISRG LLY PODD SYK

Jul 23, 2025, 12:10 PM EDT - 4 weeks ago

Boston Scientific Corporation (BSX) Q2 2025 Earnings Call Transcript

Jul 23, 2025, 10:46 AM EDT - 4 weeks ago

Cramer's Stop Trading: Boston Scientific

Jul 23, 2025, 7:58 AM EDT - 4 weeks ago

Boston Scientific lifts annual profit view on steady heart devices demand

Jul 23, 2025, 6:30 AM EDT - 4 weeks ago

Boston Scientific announces results for second quarter 2025

Jul 22, 2025, 11:00 AM EDT - 4 weeks ago

How To Trade Boston Scientific Stock Ahead Of Its Upcoming Earnings?

Jul 11, 2025, 5:05 AM EDT - 6 weeks ago

North America Ureteroscopes Market Outlook Report 2018-2033 with an Overview of Key Companies - Boston Scientific, KARL STORZ, Olympus, PENTAX Medical, and Richard Wolf

Jul 7, 2025, 7:00 AM EDT - 6 weeks ago

Boston Scientific receives FDA approval for expanded labeling of FARAPULSE™ Pulsed Field Ablation System

Jul 1, 2025, 8:00 AM EDT - 7 weeks ago

Boston Scientific announces conference call discussing second quarter 2025 results

Jun 17, 2025, 8:00 AM EDT - 2 months ago

I'm Buying Dividend Aristocrats At Bargain Basement Prices

JNJ KO MDT PEP

Jun 16, 2025, 11:00 AM EDT - 2 months ago

What's Happening With Boston Scientific Stock?

Jun 10, 2025, 10:53 AM EDT - 2 months ago

20 stocks bucking bad trends on Wall Street — what might be next for them?

AMT ANET AVGO TRMB BAC C CCL

Jun 6, 2025, 2:42 PM EDT - 2 months ago

3 Growth Stocks That Aren't the Magnificent 7

CYBR

May 30, 2025, 4:45 AM EDT - 3 months ago

Boston Scientific: Old, Reliable; Buy For Their Consistent Growth

May 28, 2025, 3:40 PM EDT - 3 months ago

Boston Scientific Scraps This Aortic Valve, Sticks To 2025 Outlook

May 28, 2025, 12:14 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 28, 2025, 8:09 AM EDT - 3 months ago

Boston Scientific to not seek US approval for heart device amid regulatory challenges

May 13, 2025, 3:33 PM EDT - 3 months ago

Boston Scientific Corporation (BSX) Bank of America's 2025 Health Care Conference (Transcript)

May 1, 2025, 8:00 AM EDT - 4 months ago

Boston Scientific announces upcoming investor conference schedule

Apr 29, 2025, 11:30 AM EDT - 4 months ago

Baron Health Care Fund Q1 2025 Top Contributors And Detractors

ACLX DHR GKOS INSM ISRG LLY RDNT

Apr 24, 2025, 3:41 PM EDT - 4 months ago

Second phase of ADVANTAGE AF study of FARAPULSE™ Pulsed Field Ablation System meets primary safety and efficacy endpoints

Apr 24, 2025, 2:13 PM EDT - 4 months ago

Boston Scientific Analysts Boost Their Forecasts Following Upbeat Results

Apr 23, 2025, 11:34 AM EDT - 4 months ago

Boston Scientific Corporation (BSX) Q1 2025 Earnings Call Transcript

Apr 23, 2025, 10:22 AM EDT - 4 months ago

Boston Scientific Raises Annual Outlook After Strong Heart Devices Sales In Q1, Announces CFO Transition

Apr 23, 2025, 9:56 AM EDT - 4 months ago

Boston Scientific Stock Surges on Strong Results, Outlook; CFO To Retire

Apr 23, 2025, 8:11 AM EDT - 4 months ago

Boston Scientific raises 2025 profit forecast on strong heart device sales

Apr 23, 2025, 6:45 AM EDT - 4 months ago

Boston Scientific Chief Financial Officer (CFO) Dan Brennan to retire; Jon Monson, senior vice president, Investor Relations to succeed Brennan

Apr 23, 2025, 6:30 AM EDT - 4 months ago

Boston Scientific announces results for first quarter 2025

Apr 1, 2025, 4:35 PM EDT - 5 months ago

Goldman Sachs Thinks These Stocks Are ‘Insulated' From a Trade War

PCG

Apr 1, 2025, 8:00 AM EDT - 5 months ago

Boston Scientific announces conference call discussing first quarter 2025 results

Mar 4, 2025, 1:00 PM EST - 6 months ago

Boston Scientific Corporation (BSX) TD Cowen 45th Annual Healthcare Conference (Transcript)

Mar 3, 2025, 6:58 AM EST - 6 months ago

Boston Scientific announces agreement to acquire SoniVie Ltd.

Feb 26, 2025, 4:15 PM EST - 6 months ago

Boston Scientific announces completion of €1.5 billion offering of senior notes

Feb 24, 2025, 11:50 AM EST - 6 months ago

Balloon Catheters Patent Landscape Report 2025, with Profiles of Cook Medical Technologies, Boston Scientific Scimed, Scimed Life Systems, Terumo Corp and Advanced Cardiovascular System

Feb 21, 2025, 9:35 PM EST - 6 months ago

Boston Scientific announces pricing of €1.5 billion of senior notes

Feb 19, 2025, 8:00 AM EST - 6 months ago

Boston Scientific to participate in TD Cowen's 45th Annual Health Care Conference

Feb 12, 2025, 7:00 AM EST - 6 months ago

What's Behind The 130% Rise In BSX Stock?

Feb 5, 2025, 11:31 AM EST - 7 months ago

Boston Scientific Corporation (BSX) Q4 2024 Earnings Call Transcript

Feb 5, 2025, 7:56 AM EST - 7 months ago

Boston Scientific sees higher-than-expected 2025 profit on strong demand

Feb 5, 2025, 6:37 AM EST - 7 months ago

Boston Scientific announces results for fourth quarter and full year 2024

Jan 21, 2025, 6:06 AM EST - 7 months ago

Top 4 Health Care Stocks You May Want To Dump In Q1

BBIO ISRG ITCI

Jan 16, 2025, 5:33 PM EST - 7 months ago

Late-breaking data presented at AF Symposium 2025 highlight key Boston Scientific therapies for management of patients with atrial fibrillation

Jan 15, 2025, 6:10 AM EST - 7 months ago

Boston Scientific Jumps Ahead of Earnings

Jan 10, 2025, 1:13 PM EST - 7 months ago

Stocks on the move: Delta, Constellation Energy, Wynn, Sweetgreen and Boston Scientific

CEG DAL SG WYNN

Jan 8, 2025, 2:07 PM EST - 8 months ago

Final Trades: Apollo, UnitedHealth, Boston Scientific and the IYF

UNH APO IYF

Jan 8, 2025, 12:25 PM EST - 8 months ago

Boston Scientific Expands Cardiovascular Treatment Portfolio With $440 Million+ Bolt Medical Deal

Jan 8, 2025, 7:00 AM EST - 8 months ago

Boston Scientific Announces Agreement to Acquire Bolt Medical, Inc.

ZacksResearch Aug. 22 at 1:08 PM

0 · Reply

BidToBlack Aug. 22 at 3:23 AM

$BSX Medical device company with strong product pipeline and exposure to structural heart and rhythm management

0 · Reply

SilverEagle Aug. 21 at 3:27 PM

$ABT $ABBV $MDT $BSX $XLV

0 · Reply

iSayStupidStuff Aug. 21 at 11:49 AM

$BSX that’s great but I only want it if it’s going up and I’m not seeing volume coming in.

0 · Reply

JFDI Aug. 20 at 10:58 PM

$BSX not BSC

0 · Reply

WAJeff Aug. 20 at 8:40 PM

Added more $BSX 106.20, $HALO 71.05

2 · Reply

SilverEagle Aug. 20 at 8:17 PM

$BSX 120-125 to complete the measured move. Then sideways.

2 · Reply

TechTraderGrok Aug. 20 at 8:05 PM

0 · Reply

BioTechHealthX Aug. 20 at 6:18 PM

0 · Reply

JFDI Aug. 20 at 5:00 PM

$BSX fav set up rn

0 · Reply

alan93 Aug. 20 at 4:29 PM

$BSX

0 · Reply

StockAutoPro Aug. 18 at 4:47 AM

$BSX: Buy target $101.17 Sell target $108.33 Strong quarterly earnings suggest potential upside for this prominent biotech firm.

0 · Reply

OptionRunners Aug. 14 at 6:51 PM

$BSX Seller of the September 12th $107/$100 short strangles 2,500 times for $1.95

0 · Reply

StockAutoPro Aug. 14 at 3:22 PM

$BSX: Buy target $100.91 Sell target $108.06 Expect potential growth in medical device company due to increased demand in healthcare sector.

0 · Reply

OptionRunners Aug. 14 at 1:46 PM

Sold $BSX calls at $1.55 for a small profit. Can't hold any bounces.

0 · Reply

TechTraderGrok Aug. 13 at 8:49 PM

Sold $BSX at $102.62 (-1.1%). From Grok: "Exiting the long position as the trend has become unclear with price below both EMA and SMA, recent pullback testing lower supports without clear recovery signals, and no upcoming catalysts to justify holding amid weakening momentum." https://www.techtrader.ai/grokwall/?post=14419&utm_source=dlvr.it&utm_medium=stocktwits

0 · Reply

OptionRunners Aug. 12 at 4:22 PM

Bought $BSX September 19th $105 calls at $1.42 for a swing

0 · Reply

StockAutoPro Aug. 12 at 2:42 PM

$BSX: Buy target $101.27 Sell target $108.43 Significant growth potential observed in leading biotech firm due to innovative pipeline and strategic partnerships.

0 · Reply

StockAutoPro Aug. 11 at 4:29 PM

$BSX: Buy target $101.15 Sell target $108.31 Strong earnings report indicates potential growth for this leading biotechnology company.

0 · Reply

thinkandpick Aug. 9 at 5:29 AM

$RMD $BDX $BSX $INSM Respiratory care industry. RMD has very high multiples at the current price levels. Specifically, RMD's EV-to Revenue and EV-to-adj. EBITDA currently exceed 5 times and 15 times, respectively. For comparison, Viemed Healthcare (VMD) $VMD has very low multiples. Specifically, VMD's EV-to-Revenue and EV-to-adj. EBITDA currently are 1 times and 4 times, respectively: https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/viemed-healthcare-announces-second-quarter-2025-financial-results-1057178

0 · Reply

Skies88 Aug. 6 at 3:51 PM

$BSX FDA Provides Early Alert On Defibrillation Lead Issue From Boston Scientific; Certain ENDOTAK RELIANCE Defibrillation Leads With Expanded ePTFE Coated Coils May Impact Shock Efficacy And/or Require Early Replacement

0 · Reply

cabeln Aug. 6 at 12:48 AM

$BSX all medical is down. I think we gap up to $112-$115 after the new bill gets more clarity

1 · Reply

Market Cap	153.73B
Revenue (ttm)	16.75B
Net Income (ttm)	1.85B
EPS (ttm)	N/A
PE Ratio	36.66
Forward PE	34.86
Profit Margin	11.07%
Debt to Equity Ratio	0.51

Volume	5,926,800
Avg Vol	7,347,024
Day's Range	N/A - N/A
Shares Out	1.48B
Stochastic %K	94%
Beta	0.66
Analysts	Strong Sell
Price Target	$125.03